DK1232141T3 - Ethere af O-desmethylvenlafaxin - Google Patents

Ethere af O-desmethylvenlafaxin

Info

Publication number
DK1232141T3
DK1232141T3 DK00980588T DK00980588T DK1232141T3 DK 1232141 T3 DK1232141 T3 DK 1232141T3 DK 00980588 T DK00980588 T DK 00980588T DK 00980588 T DK00980588 T DK 00980588T DK 1232141 T3 DK1232141 T3 DK 1232141T3
Authority
DK
Denmark
Prior art keywords
desmethylvenlafaxine
ethers
Prior art date
Application number
DK00980588T
Other languages
English (en)
Inventor
John Patrick Yardley
John William Ullrich
Magid Abdel-Megid Abou-Gharbia
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1232141T3 publication Critical patent/DK1232141T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
DK00980588T 1999-11-24 2000-11-21 Ethere af O-desmethylvenlafaxin DK1232141T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44826899A 1999-11-24 1999-11-24
PCT/US2000/031895 WO2001038293A1 (en) 1999-11-24 2000-11-21 Ethers of o-desmethyl venlafaxine

Publications (1)

Publication Number Publication Date
DK1232141T3 true DK1232141T3 (da) 2004-11-29

Family

ID=23779642

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00980588T DK1232141T3 (da) 1999-11-24 2000-11-21 Ethere af O-desmethylvenlafaxin

Country Status (25)

Country Link
EP (1) EP1232141B1 (da)
JP (1) JP2003514889A (da)
KR (1) KR100843991B1 (da)
CN (2) CN1636559A (da)
AR (1) AR024498A1 (da)
AT (1) ATE278659T1 (da)
AU (1) AU767835B2 (da)
BR (1) BR0015795A (da)
CA (1) CA2391288A1 (da)
CZ (1) CZ20021816A3 (da)
DE (1) DE60014693T2 (da)
DK (1) DK1232141T3 (da)
ES (1) ES2228636T3 (da)
HK (1) HK1045835A1 (da)
HU (1) HUP0203594A2 (da)
IL (2) IL149531A0 (da)
MX (1) MXPA02005174A (da)
NO (1) NO20022446D0 (da)
NZ (1) NZ519130A (da)
PL (1) PL202846B1 (da)
PT (1) PT1232141E (da)
SI (1) SI1232141T1 (da)
TW (1) TWI268919B (da)
WO (1) WO2001038293A1 (da)
ZA (1) ZA200204986B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
PT2621891T (pt) * 2010-10-01 2020-02-04 Shan Dong Luye Pharm Co Ltd Polimorfos de cloridrato de 4-metilbenzoato de 4-[2- dimetilamino-1-(1-hidroxiciclohexil)etil]fenilo, métodos para a preparação dos mesmos e utilização dos mesmos
CN103319373B (zh) * 2012-03-23 2017-09-19 浙江九洲药业股份有限公司 1‑[2‑氨基‑1‑(4‑苄氧基苯基)乙基]环己烷醇的制备方法及相关中间体

Also Published As

Publication number Publication date
JP2003514889A (ja) 2003-04-22
EP1232141B1 (en) 2004-10-06
DE60014693D1 (en) 2004-11-11
CN1198793C (zh) 2005-04-27
CN1399626A (zh) 2003-02-26
PL355171A1 (en) 2004-04-05
KR20030058931A (ko) 2003-07-07
WO2001038293A1 (en) 2001-05-31
DE60014693T2 (de) 2005-03-10
IL149531A (en) 2008-12-29
AU1783301A (en) 2001-06-04
PT1232141E (pt) 2004-12-31
NZ519130A (en) 2003-09-26
AR024498A1 (es) 2002-10-02
CA2391288A1 (en) 2001-05-31
EP1232141A1 (en) 2002-08-21
ZA200204986B (en) 2003-09-27
KR100843991B1 (ko) 2008-07-07
IL149531A0 (en) 2002-11-10
NO20022446L (no) 2002-05-23
MXPA02005174A (es) 2002-11-07
AU767835B2 (en) 2003-11-27
HK1045835A1 (en) 2002-12-13
TWI268919B (en) 2006-12-21
SI1232141T1 (en) 2004-12-31
ES2228636T3 (es) 2005-04-16
BR0015795A (pt) 2002-07-23
PL202846B1 (pl) 2009-07-31
CN1636559A (zh) 2005-07-13
HUP0203594A2 (en) 2003-02-28
NO20022446D0 (no) 2002-05-23
ATE278659T1 (de) 2004-10-15
CZ20021816A3 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
EE05421B1 (et) Fulvestrandi formulatsioonid
DE60114714D1 (de) Silikon-Entschäumer-Zusammensetzung
IS2325B (is) Örgerðar samsetningar epleróns
DE69933200D1 (de) Kombinierte impfstoffzusammensetzungen
ATE476975T1 (de) Abführende zusammensetzungen
ATE303787T1 (de) Schergelzusammensetzungen
NO20003815L (no) Sammensetninger omfattende celecoxib
FI20010780A0 (fi) Parannetut koostumukset
DK1309327T3 (da) Farmaceutiske sammensætninger af østrogene midler
AR028197A1 (es) Composiciones antitranspirantes
DK1237408T3 (da) Hæld-på-formuleringer
PT1250321E (pt) Composicao de gliburida
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE50203030D1 (de) Befeuchtungszelle
DE60007044D1 (de) Stabile biozide Zusammensetzungen
DK1337228T3 (da) Sammensætninger til fjernelse af human cerumen
PT1238587E (pt) Composicoes de biopesticidas
DE60103258D1 (de) Gesicherte dienste
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
IS6620A (is) Nýr fjölgervingur V af tórasemíði
DK1232141T3 (da) Ethere af O-desmethylvenlafaxin
FI20011778A (fi) Ryhmälähetyksen toteutus
DK1088010T3 (da) Fremstilling af polyolefiner
DE60136332D1 (de) Verbindungsdienste
DK1358781T3 (da) Faceplate